Suppr超能文献

用于检测 BRCA1 突变的天然 DNA 单步捕获和测序。

Single-step capture and sequencing of natural DNA for detection of BRCA1 mutations.

机构信息

Helicos BioSciences Corporation, Cambridge, Massachusetts 02139, USA.

出版信息

Genome Res. 2012 Feb;22(2):340-5. doi: 10.1101/gr.122192.111. Epub 2011 Jul 15.

Abstract

Genetic testing for disease risk is an increasingly important component of medical care. However, testing can be expensive, which can lead to patients and physicians having limited access to the genetic information needed for medical decisions. To simplify DNA sample preparation and lower costs, we have developed a system in which any gene can be captured and sequenced directly from human genomic DNA without amplification, using no proteins or enzymes prior to sequencing. Extracted whole-genome DNA is acoustically sheared and loaded in a flow cell channel for single-molecule sequencing. Gene isolation, amplification, or ligation is not necessary. Accurate and low-cost detection of DNA sequence variants is demonstrated for the BRCA1 gene. Disease-causing mutations as well as common variants from well-characterized samples are identified. Single-molecule sequencing generates very reproducible coverage patterns, and these can be used to detect any size insertion or deletion directly, unlike PCR-based methods, which require additional assays. Because no gene isolation or amplification is required for sequencing, the exceptionally low costs of sample preparation and analysis could make genetic tests more accessible to those who wish to know their own disease susceptibility. Additionally, this approach has applications for sequencing integration sites for gene therapy vectors, transposons, retroviruses, and other mobile DNA elements in a more facile manner than possible with other methods.

摘要

疾病风险的基因检测是医疗保健中越来越重要的组成部分。然而,检测可能很昂贵,这可能导致患者和医生无法获得做出医疗决策所需的遗传信息。为了简化 DNA 样本制备并降低成本,我们开发了一种系统,无需在测序前使用任何蛋白质或酶,即可直接从人类基因组 DNA 中捕获和测序任何基因,而无需扩增。提取的全基因组 DNA 经声剪切并加载到用于单分子测序的流道中。不需要基因分离、扩增或连接。对 BRCA1 基因进行了 DNA 序列变异的准确且低成本的检测。从特征明确的样本中鉴定出致病突变和常见变异。单分子测序产生非常可重复的覆盖模式,并且可以直接用于检测任何大小的插入或缺失,而不同于基于 PCR 的方法,后者需要额外的检测。由于测序不需要基因分离或扩增,因此样品制备和分析的成本极低,这使得那些希望了解自己疾病易感性的人更容易进行基因测试。此外,与其他方法相比,这种方法更便于以更简单的方式对基因治疗载体、转座子、逆转录病毒和其他移动 DNA 元件的整合位点进行测序。

相似文献

引用本文的文献

4
PALB2 and breast cancer: ready for clinical translation!PALB2与乳腺癌:准备好进行临床转化了!
Appl Clin Genet. 2013 Jul 19;6:43-52. doi: 10.2147/TACG.S34116. Print 2013.
7
Third-generation sequencing techniques and applications to drug discovery.第三代测序技术及其在药物发现中的应用。
Expert Opin Drug Discov. 2012 Mar;7(3):231-43. doi: 10.1517/17460441.2012.660145. Epub 2012 Feb 2.
9
Genomic sequencing in clinical trials.基因组测序在临床试验中的应用。
J Transl Med. 2011 Dec 30;9:222. doi: 10.1186/1479-5876-9-222.

本文引用的文献

7
A transposon and transposase system for human application.用于人类应用的转座子和转座酶系统。
Mol Ther. 2010 Apr;18(4):674-83. doi: 10.1038/mt.2010.2. Epub 2010 Jan 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验